Zimmer Biomet to Acquire Medtech Surgical Robotics Company

July 18, 2016


Zimmer Biomet (ZBH) announced its plans to acquire Medtech, provider of surgical systems including the ROSA™ Spine robotic-assistive device for minimally invasive surgery.

ZBH acquired 1.4MM Medtech shares, representing 58.77% of the outstanding share capital from selling stockholders in a private transaction, as well as all outstanding convertible bonds and warrants previously issued by Medtech. Shares were acquired for €50.00 each, convertible bonds at €50.03 each and warrants at €17.17 each (~US $55.3, $55.3 and $19.0, respectively). ZBH will shortly launch an all-cash simplified tender offer to acquire remaining outstanding shares of Medtech for the same price per share.

ZBH intends to continue operations at Medtech’s headquarters in Montpellier, France, as a center of excellence for robotic development activities. Bertin Nahum, current Medtech CEO, is intended to remain at the helm.

Founded in 2002, Medtech has developed ROSA for use in spine and cranial procedures requiring surgical planning with pre-op data, patient registration and precise positioning and handling of instruments.

in 2Q16, Medtech announced that 100 spinal surgeries have been successfully performed with the ROSA. The system received CE Mark approval in 2014 and FDA 510(k) clearance in 1Q16.

Other companies active in the spine/robotics space include:

Today’s announcement includes no indication of ZBH’s intentions for ROSA’s cranial application. While ZBH presently offers computer-assisted technologies for surgeon use with its hip and knee reconstruction systems, the company has not previously offered surgical robotics.

Sources: Zimmer Biomet Inc. (Form 8-K), ORTHOWORLD Inc.,


Drue is Managing Partner for The De Angelis Group.

Related Articles

Back to top button